A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...

Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.

From Monday 31 March, the stroke team at the Luton and Dunstable University Hospital (L&D) will be working with colleagues at ...

This innovation has the potential to transform clinical workflows by enhancing ... also shed light on the underlying neural ...

Two studies, presented at the International Stroke Conference ... and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant ...